Page last updated: 2024-10-21

vanilmandelic acid and Leukemia

vanilmandelic acid has been researched along with Leukemia in 2 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Helson, L1
Johnson, GA1
Smith, R1
Bostrom, B1
Mirkin, BL1

Other Studies

2 other studies available for vanilmandelic acid and Leukemia

ArticleYear
DOPA metabolism in neuroblastoma.
    Medical and pediatric oncology, 1980, Volume: 8, Issue:4

    Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Dihydroxyphenylalanine; False Negative Reactions

1980
Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:7

    Topics: Brain Neoplasms; Eye Neoplasms; Glycols; Homovanillic Acid; Humans; Leukemia; Methoxyhydroxyphenylgl

1987